Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amanda Corley

Showing results (71-80 of 85) with videos related to

Pageof 9
Sort By:
Clinical Pharmacokinetics|March 7, 2022
Population Pharmacokinetics and Dosing Simulations of Ceftriaxone in Critically Ill Patients Receiving Extracorporeal Membrane Oxygenation (An ASAP ECMO Study)Vesa Cheng, Mohd H Abdul-Aziz, Fay Burrows, et al.
International Journal of Antimicrobial Agents|October 24, 2021
Population pharmacokinetics of cefepime in critically ill patients receiving extracorporeal membrane oxygenation (an ASAP ECMO study)Vesa Cheng, Mohd H Abdul-Aziz, Fay Burrows, et al.
BMJ Open|September 25, 2015
Securing All intraVenous devices Effectively in hospitalised patients--the SAVE trial: study protocol for a multicentre randomised controlled trialClaire M Rickard, Nicole Marsh, Joan Webster, et al.
Critical Care Medicine|February 21, 2025
Securing Jugular Central Venous Catheters With Dressings Fixed to a Liquid Adhesive to Prevent Dressing Failure in Intensive Care Patients (the STICKY Trial): A Randomized Controlled TrialNicole Marsh, Catherine O'Brien, Emily N Larsen, et al.
BMJ Open|February 5, 2015
Intravascular device administration sets: replacement after standard versus prolonged use in hospitalised patients-a study protocol for a randomised controlled trial (The RSVP Trial)Claire M Rickard, Nicole M Marsh, Joan Webster, et al.
Antimicrobial Agents and Chemotherapy|December 8, 2023
Population pharmacokinetics of fluconazole in critically ill patients receiving extracorporeal membrane oxygenation and continuous renal replacement therapy: an ASAP ECMO studyEmmanuel Novy, Mohd H Abdul-Aziz, Vesa Cheng, et al.
The Journal of Antimicrobial Chemotherapy|March 11, 2026
Population pharmacokinetics of meropenem in critically ill adult patients receiving extracorporeal membrane oxygenation-an ASAP ECMO studyMohd H Abdul-Aziz, Vesa Cheng, Fay Burrows, et al.
Lancet (London, England)|April 18, 2021
Effect of infusion set replacement intervals on catheter-related bloodstream infections (RSVP): a randomised, controlled, equivalence (central venous access device)-non-inferiority (peripheral arterial catheter) trialClaire M Rickard, Nicole M Marsh, Emily N Larsen, et al.
Antimicrobial Agents and Chemotherapy|August 30, 2021
Population Pharmacokinetics of Piperacillin and Tazobactam in Critically Ill Patients Receiving Extracorporeal Membrane Oxygenation: an ASAP ECMO StudyVesa Cheng, Mohd H Abdul-Aziz, Fay Burrows, et al.
American Journal of Respiratory and Critical Care Medicine|October 10, 2022
Antimicrobial Exposures in Critically Ill Patients Receiving Extracorporeal Membrane OxygenationKiran Shekar, Mohd H Abdul-Aziz, Vesa Cheng, et al.
Pageof 9

Showing results (71-80 of 85) with videos related to

Sort By:
Pageof 9
Clinical Pharmacokinetics|March 7, 2022
Population Pharmacokinetics and Dosing Simulations of Ceftriaxone in Critically Ill Patients Receiving Extracorporeal Membrane Oxygenation (An ASAP ECMO Study)Vesa Cheng, Mohd H Abdul-Aziz, Fay Burrows, et al.
International Journal of Antimicrobial Agents|October 24, 2021
Population pharmacokinetics of cefepime in critically ill patients receiving extracorporeal membrane oxygenation (an ASAP ECMO study)Vesa Cheng, Mohd H Abdul-Aziz, Fay Burrows, et al.
BMJ Open|September 25, 2015
Securing All intraVenous devices Effectively in hospitalised patients--the SAVE trial: study protocol for a multicentre randomised controlled trialClaire M Rickard, Nicole Marsh, Joan Webster, et al.
Critical Care Medicine|February 21, 2025
Securing Jugular Central Venous Catheters With Dressings Fixed to a Liquid Adhesive to Prevent Dressing Failure in Intensive Care Patients (the STICKY Trial): A Randomized Controlled TrialNicole Marsh, Catherine O'Brien, Emily N Larsen, et al.
BMJ Open|February 5, 2015
Intravascular device administration sets: replacement after standard versus prolonged use in hospitalised patients-a study protocol for a randomised controlled trial (The RSVP Trial)Claire M Rickard, Nicole M Marsh, Joan Webster, et al.
Antimicrobial Agents and Chemotherapy|December 8, 2023
Population pharmacokinetics of fluconazole in critically ill patients receiving extracorporeal membrane oxygenation and continuous renal replacement therapy: an ASAP ECMO studyEmmanuel Novy, Mohd H Abdul-Aziz, Vesa Cheng, et al.
The Journal of Antimicrobial Chemotherapy|March 11, 2026
Population pharmacokinetics of meropenem in critically ill adult patients receiving extracorporeal membrane oxygenation-an ASAP ECMO studyMohd H Abdul-Aziz, Vesa Cheng, Fay Burrows, et al.
Lancet (London, England)|April 18, 2021
Effect of infusion set replacement intervals on catheter-related bloodstream infections (RSVP): a randomised, controlled, equivalence (central venous access device)-non-inferiority (peripheral arterial catheter) trialClaire M Rickard, Nicole M Marsh, Emily N Larsen, et al.
Antimicrobial Agents and Chemotherapy|August 30, 2021
Population Pharmacokinetics of Piperacillin and Tazobactam in Critically Ill Patients Receiving Extracorporeal Membrane Oxygenation: an ASAP ECMO StudyVesa Cheng, Mohd H Abdul-Aziz, Fay Burrows, et al.
American Journal of Respiratory and Critical Care Medicine|October 10, 2022
Antimicrobial Exposures in Critically Ill Patients Receiving Extracorporeal Membrane OxygenationKiran Shekar, Mohd H Abdul-Aziz, Vesa Cheng, et al.
Pageof 9